Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruby Mehta

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Indian Journal of Dermatology|November 29, 2011
When fue goes wrong!Arvind Poswal, Sangay Bhutia, Ruby Mehta
Hepatology (Baltimore, Md.)|March 26, 2018
Design and Endpoints for Clinical Trials in Primary Sclerosing CholangitisCyriel Y Ponsioen, Keith D Lindor, Ruby Mehta, et al.
Alimentary Pharmacology & Therapeutics|October 25, 2023
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver ForumMelissa Palmer, David E Kleiner, Zachary Goodman, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Indian Journal of Dermatology|November 29, 2011
When fue goes wrong!Arvind Poswal, Sangay Bhutia, Ruby Mehta
Hepatology (Baltimore, Md.)|March 26, 2018
Design and Endpoints for Clinical Trials in Primary Sclerosing CholangitisCyriel Y Ponsioen, Keith D Lindor, Ruby Mehta, et al.
Alimentary Pharmacology & Therapeutics|October 25, 2023
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver ForumMelissa Palmer, David E Kleiner, Zachary Goodman, et al.
Pageof 1